Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension.
Pei-Jing CuiJing YaoYin ZhuZheng-Yun ZhangJun YangPublished in: Gastroenterology research and practice (2017)
Prolonged administration of OCT-LAR exerted a virtually similar effect on improving hemodynamic parameters and liver function in patients with portal hypertension compared with placement of TIPS, with no apparent serious adverse effects.